These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

157 related items for PubMed ID: 28316982

  • 1. Hidden IgG Antibodies to the Tumor-Associated Thomsen-Friedenreich Antigen in Gastric Cancer Patients: Lectin Reactivity, Avidity, and Clinical Relevance.
    Kurtenkov O, Klaamas K.
    Biomed Res Int; 2017; 2017():6097647. PubMed ID: 28316982
    [Abstract] [Full Text] [Related]

  • 2. Aberrant glycosylation of the anti-Thomsen-Friedenreich glycotope immunoglobulin G in gastric cancer patients.
    Kodar K, Izotova J, Klaamas K, Sergeyev B, Järvekülg L, Kurtenkov O.
    World J Gastroenterol; 2013 Jun 21; 19(23):3573-82. PubMed ID: 23801858
    [Abstract] [Full Text] [Related]

  • 3. The Thomsen-Friedenreich antigen and alphaGal-specific human IgG glycoforms: concanavalin A reactivity and relation to survival of cancer patients.
    Kodar K, Kurtenkov O, Klaamas K.
    Immunol Invest; 2009 Jun 21; 38(8):704-17. PubMed ID: 19860583
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. IgG immune response to tumor-associated carbohydrate antigens (TF, Tn, alphaGal) in patients with breast cancer: impact of neoadjuvant chemotherapy and relation to the survival.
    Kurtenkov O, Klaamas K, Rittenhouse-Olson K, Vahter L, Sergejev B, Miljukhina L, Shljapnikova L.
    Exp Oncol; 2005 Jun 21; 27(2):136-40. PubMed ID: 15995632
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Active immunization of human ovarian cancer patients against a common carcinoma (Thomsen-Friedenreich) determinant using a synthetic carbohydrate antigen.
    MacLean GD, Bowen-Yacyshyn MB, Samuel J, Meikle A, Stuart G, Nation J, Poppema S, Jerry M, Koganty R, Wong T.
    J Immunother (1991); 1992 May 21; 11(4):292-305. PubMed ID: 1599915
    [Abstract] [Full Text] [Related]

  • 15. The relation of serum anti-(GalNAc beta) and -para-Forssman disaccharide IgG levels to the progression and histological grading of gastrointestinal cancer.
    Smorodin EP, Kurtenkov OA, Sergeyev BL, Chuzmarov VI, Afanasyev VP.
    Exp Oncol; 2007 Mar 21; 29(1):61-6. PubMed ID: 17431391
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Cluster binding studies with two anti-Thomsen-Friedenreich (anti-core-1, CD176, TF) antibodies: Evidence for a multiple TF epitope.
    Flechner A, Butschak G, Löffler A, Rühmann J, Nishimura SI, Dölling R, Purfürst B, Goletz S, Danielczyk A, Karsten U.
    Int Immunopharmacol; 2019 Jul 21; 72():186-194. PubMed ID: 30999209
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.